PLIVA Acquires Uso Racional in Spain

17-Feb-2006

PLIVA d.d. announced that an agreement has been signed with Novartis' generics division, Sandoz, for the purchase of its Spanish subsidiary Uso Racional S.L (UR) for a total cash consideration of EUR 21.5m. With expected sales of about EUR 12m in 2006, UR represents a well known and established generics brand in Spain, with a small dedicated sales force and a complementary product portfolio and attractive pipeline. The acquisition of UR represents a strong strategic fit with PLIVA's current Spanish operations, which PLIVA expects to help it significantly strengthen its position and performance on this market.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...